L E Nomura1, J M Walker, H T Maecker. 1. Biological Research and Development, BD Biosciences, Immunocytometry Systems, San Jose, CA 95131, USA.
Abstract
BACKGROUND: The analysis of cytokine production is a valuable component of studies of immune response to stimulation such as pathogens, vaccines, and other immunological challenges. One highly sensitive method of cytokine evaluation involves three-color flow cytometric analysis of cytokine production in individual CD4(+) T cells. METHODS: We present four methods to enhance the acquisition and analysis of cells secreting the cytokines interferon gamma (IFNgamma), tumor necrosis factor alpha (TNFalpha), interleukin-2 (IL-2), and interleukin-4 (IL-4). Using cytomegalovirus (CMV) as the antigenic model, titration and kinetic experiments were carried out in whole blood from CMV-seropositive donors. RESULTS: CMV is most effective as a stimulating antigen when used at a dose of 5 microg/ml and for a period of at least 6 h, the first 2 h in the absence of 10 microg/ml Brefeldin A. This period of incubation can be made more convenient by the use of a "timed cooling" device, whereby the samples are automatically cooled and held at 4 degrees C at the end of incubation. Such timed cooling does not affect backgrounds or the proportion of responding cells. For certain samples, a high background can be reduced by adding fourth-color reagents. They identify and allow for elimination of monocytes and activated platelets, which contribute to false positive staining. CONCLUSIONS: These optimizations make the assay both convenient for use in whole blood samples and highly reproducible (intra-assay variability is less than 10%; interassay variability is less than 25%). Copyright 2000 Wiley-Liss, Inc.
BACKGROUND: The analysis of cytokine production is a valuable component of studies of immune response to stimulation such as pathogens, vaccines, and other immunological challenges. One highly sensitive method of cytokine evaluation involves three-color flow cytometric analysis of cytokine production in individual CD4(+) T cells. METHODS: We present four methods to enhance the acquisition and analysis of cells secreting the cytokines interferon gamma (IFNgamma), tumornecrosis factor alpha (TNFalpha), interleukin-2 (IL-2), and interleukin-4 (IL-4). Using cytomegalovirus (CMV) as the antigenic model, titration and kinetic experiments were carried out in whole blood from CMV-seropositive donors. RESULTS: CMV is most effective as a stimulating antigen when used at a dose of 5 microg/ml and for a period of at least 6 h, the first 2 h in the absence of 10 microg/ml Brefeldin A. This period of incubation can be made more convenient by the use of a "timed cooling" device, whereby the samples are automatically cooled and held at 4 degrees C at the end of incubation. Such timed cooling does not affect backgrounds or the proportion of responding cells. For certain samples, a high background can be reduced by adding fourth-color reagents. They identify and allow for elimination of monocytes and activated platelets, which contribute to false positive staining. CONCLUSIONS: These optimizations make the assay both convenient for use in whole blood samples and highly reproducible (intra-assay variability is less than 10%; interassay variability is less than 25%). Copyright 2000 Wiley-Liss, Inc.
Authors: F Bolacchi; A Sinistro; C Ciaprini; F Demin; M Capozzi; F C Carducci; C M J Drapeau; G Rocchi; A Bergamini Journal: Clin Exp Immunol Date: 2006-05 Impact factor: 4.330
Authors: Maria C Jaimes; Holden T Maecker; Ming Yan; Vernon C Maino; Mary Beth Hanley; Angela Greer; Janice M Darden; M Patricia D'Souza Journal: J Immunol Methods Date: 2010-08-19 Impact factor: 2.303
Authors: Helen Horton; Evan P Thomas; Jason A Stucky; Ian Frank; Zoe Moodie; Yunda Huang; Ya-Lin Chiu; M Juliana McElrath; Stephen C De Rosa Journal: J Immunol Methods Date: 2007-04-03 Impact factor: 2.303
Authors: Patricio Escalante; Tobias Peikert; Virginia P Van Keulen; Courtney L Erskine; Cathy L Bornhorst; Boleyn R Andrist; Kevin McCoy; Larry R Pease; Roshini S Abraham; Keith L Knutson; Hirohito Kita; Adam G Schrum; Andrew H Limper Journal: Am J Respir Crit Care Med Date: 2015-09-01 Impact factor: 21.405
Authors: Yvonne J Yamanaka; Gregory L Szeto; Todd M Gierahn; Talitha L Forcier; Kelly F Benedict; Mavis S N Brefo; Douglas A Lauffenburger; Darrell J Irvine; J Christopher Love Journal: Anal Chem Date: 2012-12-03 Impact factor: 6.986
Authors: Mark J Boaz; Peter Hayes; Tony Tarragona; Laura Seamons; Andrew Cooper; Josephine Birungi; Paul Kitandwe; Aloysius Semaganda; Pontiano Kaleebu; Gwynneth Stevens; Omu Anzala; Bashir Farah; Simon Ogola; Jackton Indangasi; Patrick Mhlanga; Melanie Van Eeden; Madhuri Thakar; Ashwini Pujari; Shadri Mishra; Nilu Goonetilleke; Stephen Moore; Abdul Mahmoud; Pattabiraman Sathyamoorthy; Jayashri Mahalingam; Paranji R Narayanan; Vadakkuppattu D Ramanathan; Josephine H Cox; Len Dally; Dilbinder K Gill; Jill Gilmour Journal: Clin Vaccine Immunol Date: 2008-12-17
Authors: M J Boaz; A Waters; S Murad; P J Easterbrook; E D'Sousa; C van Wheeley; A Vyakarnam Journal: Clin Exp Immunol Date: 2003-12 Impact factor: 4.330